DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▲ |
---|---|---|---|---|---|
C0376358 | Malignant neoplasm of prostate | PPP1R3A | 5506 | protein phosphatase 1 regulatory subunit 3A | Q16821 |
C0009402 | Colorectal Carcinoma | PPP1R3A | 5506 | protein phosphatase 1 regulatory subunit 3A | Q16821 |
C1852091 | INSULIN RESISTANCE, SUSCEPTIBILITY TO | PPP1R3A | 5506 | protein phosphatase 1 regulatory subunit 3A | Q16821 |
C1332979 | Childhood Lymphoma | PPP1R3A | 5506 | protein phosphatase 1 regulatory subunit 3A | Q16821 |
C0011849 | Diabetes Mellitus | PPP1R3A | 5506 | protein phosphatase 1 regulatory subunit 3A | Q16821 |
C0027651 | Neoplasms | PPP1R3A | 5506 | protein phosphatase 1 regulatory subunit 3A | Q16821 |
C0494463 | Alzheimer Disease, Late Onset | PPP1R3A | 5506 | protein phosphatase 1 regulatory subunit 3A | Q16821 |
C0023015 | Language Disorders | PPP1R3A | 5506 | protein phosphatase 1 regulatory subunit 3A | Q16821 |
C0280324 | Laryngeal Squamous Cell Carcinoma | PPP1R3A | 5506 | protein phosphatase 1 regulatory subunit 3A | Q16821 |
C0376545 | Hematologic Neoplasms | PPP1R3A | 5506 | protein phosphatase 1 regulatory subunit 3A | Q16821 |
C0018801 | Heart failure | PPP1R3A | 5506 | protein phosphatase 1 regulatory subunit 3A | Q16821 |
C1332206 | Adult Lymphoma | PPP1R3A | 5506 | protein phosphatase 1 regulatory subunit 3A | Q16821 |
C0023903 | Liver neoplasms | PCK2 | 5106 | phosphoenolpyruvate carboxykinase 2, mitochondrial | Q16822 |
C0376358 | Malignant neoplasm of prostate | PCK2 | 5106 | phosphoenolpyruvate carboxykinase 2, mitochondrial | Q16822 |
C0345904 | Malignant neoplasm of liver | PCK2 | 5106 | phosphoenolpyruvate carboxykinase 2, mitochondrial | Q16822 |
C0006826 | Malignant Neoplasms | PCK2 | 5106 | phosphoenolpyruvate carboxykinase 2, mitochondrial | Q16822 |
C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | PCK2 | 5106 | phosphoenolpyruvate carboxykinase 2, mitochondrial | Q16822 |
C0007113 | Rectal Carcinoma | PCK2 | 5106 | phosphoenolpyruvate carboxykinase 2, mitochondrial | Q16822 |
C2711227 | Steatohepatitis | PCK2 | 5106 | phosphoenolpyruvate carboxykinase 2, mitochondrial | Q16822 |
C0015695 | Fatty Liver | PCK2 | 5106 | phosphoenolpyruvate carboxykinase 2, mitochondrial | Q16822 |
C0020456 | Hyperglycemia | PCK2 | 5106 | phosphoenolpyruvate carboxykinase 2, mitochondrial | Q16822 |
C0011847 | Diabetes | PCK2 | 5106 | phosphoenolpyruvate carboxykinase 2, mitochondrial | Q16822 |
C2239176 | Liver carcinoma | PCK2 | 5106 | phosphoenolpyruvate carboxykinase 2, mitochondrial | Q16822 |
C0027651 | Neoplasms | PCK2 | 5106 | phosphoenolpyruvate carboxykinase 2, mitochondrial | Q16822 |
C1306459 | Primary malignant neoplasm | PCK2 | 5106 | phosphoenolpyruvate carboxykinase 2, mitochondrial | Q16822 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024